Aug, 2018

U.S.A.
News / Corporate
Astellas Statement on U.S. Drug Pricing
For the remainder of 2018, Astellas will not increase any of the company’s drug prices in the United States. Astellas believes that the price of medicines should be a fair reflection of the...
Read More

Jul, 2018

U.S.A.
News / Corporate
Astellas Americas Announces Leadership Changes in Medical Affairs and Corporate Communications
Astellas Americas today announced a new vice president to its Medical Affairs Oncology therapeutic area, and newly-appointed vice president and executive director promotions in its Corporate...
Read More

May, 2018

U.S.A.
News / Corporate
Astellas Oncology C3 Prize® Returns for Third Year with Focus on Improving Cancer Care in Underserved Regions of the World
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced the launch of the third annual Astellas Oncology C3 Prize (Changing Cancer Care), a global...
Read More

Apr, 2018

U.S.A.
News / Corporate
Astellas' Nahrin Marino named a 2018 Healthcare Businesswomen's Association Luminary
Astellas today announced that Nahrin Marino, Deputy General Counsel, Legal, will be recognized as one of the most inspirational people in the life sciences industry by the Healthcare...
Read More
U.S.A.
News / Corporate
Astellas Reports Financial Results for FY2017
Sales (-0.9%) and core operating profit (-2.1%) decreased due to the impact of certain items such as the transfer of the global dermatology business in April 2016 and the transfer of long-listed...
Read More